A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment

Psychiatry and Clinical Neurosciences

Volumn 54, Issue 5, 2000, Pages 599-601

  Kawahara, Takashi ^a   Ueda, Yuto ^a   Mitsuyama, Yoshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Augmentation; Clomipramine; Obsessive compulsive disorder; Risperidone

Indexed keywords

ANXIOLYTIC AGENT; BROMAZEPAM; CHLORPROMAZINE; CLOMIPRAMINE; RISPERIDONE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; HUMAN; MALE; OBSESSION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; CLOMIPRAMINE; DRUG THERAPY, COMBINATION; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; OBSESSIVE-COMPULSIVE DISORDER; RISPERIDONE;

EID: 0033778558     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2000.00760.x     Document Type: Article

References (13)

1. Risperidone in the treatment of affective illness and obsessive-compulsive disorder
2. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: Three cases
3. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD)
4. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder
5. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders
6. Update on pharmacologic management of OCD agents and augmentation
7. Reliability and validity of the Japanese version of the yale-brown obsessive-compulsive scale
8. Current issues in the pharmacologic management of obsessive compulsive disorder
9. Differential response of psychotic and obsessive symptoms to risperidone in adolescent
10. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia
11. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder
12. 5HT-2 receptor and fluvoxamine effect in obsessive compulsive disorder
13. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics